The Pharma Data

JUNE 2, 2022

Boehringer Ingelheim and the Agency for Science, Technology and Research (A*STAR) today announced a global licensing agreement under which Boehringer Ingelheim will obtain exclusive worldwide rights to research, develop and commercialize products based on a panel of innovative, tumor-specific antibodies from A*STAR.

Licensing 52

Licensing Licensing Therapies Science 52

Drug Discovery World

SEPTEMBER 7, 2022

From research to clinical trials, FDA assessment and monitoring beyond, the process is by no means quick; anything that helps expediate the route for getting a drug to market is desirable. According to MarketsandMarkets the global AI in drug discovery market is projected to reach $1,434 million by 2024 from $259 million in 2019.

Drugs 130

Drugs Clinical Trials Licensing Licensing 130

Drug Discovery World

MAY 6, 2024

During the period 2016-2021, the Brazilian, Chinese and Indian markets grew by 11.7%, 6.7% respectively compared to an average market growth of 5.8% for the top five European Union markets and 5.6% for the US market 2. Even before this, however, Amsterdam was established as an important centre for drug development.

Drugs 147

Drugs Science Molecular Biology Clinical Trials 147

Predictive Oncology

MARCH 17, 2023

Cancer Research Horizons to incorporate PEDAL into future drug discovery processes to enable drug development on a global scale 11 marketed drugs 2nd largest oncology out-licensor globally 150+ active licenses 160+ new drugs into early-phase clinical trials $647 million revenue from royalties & IP $2.8

Research 52

Research Clinical Trials Licensing Licensing 52

Predictive Oncology

MARCH 21, 2023

Pamela Bush of Predictive Oncology discuss the potential impact of their collaboration and how it can advance cancer drug development.

Research 52

Research Licensing Licensing Drugs 52

Drug Discovery World

OCTOBER 16, 2023

From the Beatson Institute for Cancer Research in Glasgow, to Edinburgh Drug Discovery in the University of Edinburgh’s Institute for Genetics and Cancer (IGC). At ELRIG’s Scottish Research and Drug Development Forum meeting, DDW’s Diana Spencer provided a snapshot of drug discovery in Scotland.

Drugs 189

Drugs Science Therapies Targeted Protein Degradation 189

Drug Discovery World

NOVEMBER 29, 2022

The new Clinical Pharmacology degree was launched in 2019 by Professors Emma Baker and Iain Greenwood and aims to take a holistic view of the development of drugs and create graduates that will stand out in the job market. Pharmacokinetics: How the body handles drugs. Providing a broad view.

Clinical Pharmacology 130

Clinical Pharmacology Clinical Trials Drugs Drug Development 130

Perficient: Drug Development

SEPTEMBER 19, 2023

Increased Capabilities for Marketing Cloud and Commerce Cloud Salesforce introduced 26 generative AI capabilities between Marketing Cloud and Commerce Cloud, 14 of which are in GA now, with an additional 14 to arrive by the end of 2024.

Licensing 59

Licensing Licensing Production Marketing 59

The Pharma Data

OCTOBER 29, 2020

Tokyo, Japan) today announced that the European Medicines Agency (EMA) has confirmed it has accepted for review, following a standard timetable, the Marketing Authorization Application (MAA) for aducanumab, an investigational treatment for Alzheimer’s disease. have collaborated on the development and commercialization of aducanumab globally.

Marketing 40

Marketing Disease Clinical Trials Treatment 40

Drug Discovery World

JANUARY 30, 2024

To achieve this, we need greater collaboration between academia, therapy developers and manufacturing equipment developers.” Stella Vnook , CEO, Likarda , notes that a s more regenerative therapy options come to the market, patients will demand access to the treatments, often using the court system. She

Therapies 179

Therapies Clinical Trials Trials Production 179

Drug Discovery World

FEBRUARY 12, 2024

Dr Pandora Pound , Fellow Oxford Centre for Animal Ethics explores the hinderances of animal testing in pharma and why new technologies such AI, genomics and synthetic biology c an further drug development. Most animal experiments try to ‘model’ human disease at its advanced stages.

Animal Testing 147

Animal Testing Disease Trials Research 147

Drug Discovery World

SEPTEMBER 26, 2022

A report by the medical charity LifeArc 1 puts the timeframe for a therapy brought to market through repurposing methods at anywhere from one to three years. This is a stark contrast to the often decade-long projects that pharmaceutical companies undertake to bring a drug to market.

Pharmaceutical Companies 130

Pharmaceutical Companies Drugs Pharmaceuticals Clinical Trials 130

ASPET

OCTOBER 12, 2023

To maintain cadence with looming threats in a prolonged field care environment, the broader medical countermeasure (MCM) enterprise must adopt new strategies for CBRN-addressing drug development. CBRN MCMs).

Therapies 40

Therapies Licensing Licensing FDA Approval 40

Drug Discovery World

AUGUST 12, 2022

If the Phase III trial is successful, Pfizer aims to submit a Biologics License Application (BLA) to the US Food and Drug Administration (FDA) and Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) in 2025. . Official comments .

Vaccine 130

Vaccine Disease Trials Pharmaceutical Companies 130

Drug Discovery World

AUGUST 3, 2023

For example, the FDA has not approved a marketing application for cannabis for the treatment of any disease or condition to date 1. There is, however, one cannabis-derived drug product that the FDA has approved, which is Epidiolex (cannabidiol). 12 Meet the Biotech: Who is doing what with medical cannabis?

Clinical Trials 130

Clinical Trials Regulations Production FDA 130

Drug Target Review

AUGUST 9, 2024

Knowing and formulating the drug’s solubility, stability and particle size through design and addition of excipients is a continuous process throughout drug development. 1 Challenges in drug formulation Developing a successful drug formulation is fraught with challenges.

Science 59

Science Drugs Compliance Drug Development 59

Drug Discovery World

OCTOBER 4, 2022

Erhardt adds that despite the ever-increasing number of people with AD, there has been an erosion of market value (from $4.2 Oligomerix believes it is focused on the most important segment of the neuroscience market which is the Alzheimer’s/dementia space. Diseases such as PSP and FTD have no licensed and available treatments.

Disease 130

Disease Small Molecule Compound Screening Clinical Development 130

Alta Sciences

DECEMBER 14, 2023

Regulatory Excellence - Licenses for Schedule I through IV drug substances. Clinical Supply Manufacturing Integration with our manufacturing team, ensuring flexibility and adaptability to meet the evolving needs of your studies throughout your drug development program or study. 24/7 monitoring of temperature and humidity.

Compounding Pharmacies 40

Compounding Pharmacies Pharmacy Clinical Pharmacology Clinical Supply 40

Perficient: Drug Development

JANUARY 19, 2024

If you want to reduce capital and operational expenditures, speed time to market, and improve scalability, elasticity, security, and compliance, you should consider moving your on-premises IBM Sterling application to IBM supported native SaaS or other cloud solutions which best suits your business.

Compliance 118

Compliance Marketing Licensing Licensing 118

Drug Discovery World

MARCH 29, 2023

Regulatory data protection (RDP) period RDP refers to the time when generic drug makers cannot refer to an innovator drug’s data to obtain a marketing authorisation 2.

Clinical Trials 130

Clinical Trials Biosimilars Pharma Companies Production 130

Molecule Blog

AUGUST 6, 2021

An Open Bazaar for Drug Development: Molecule Protocol The complexity of biopharma IP deals When examining the transactional market for biopharma IP, one aspect becomes immediately obvious: IP is not sold in a simple purchase agreement like houses, cars or other physical objects. To achieve this, Molecule chose to use Arweave.

Licensing 52

Licensing Licensing Marketing Research 52

Perficient: Drug Development

SEPTEMBER 11, 2023

Usually, Sitecore Headless Services can be implemented using the current licensing model, providing a seamless transition for existing Sitecore users, however we have seen clients on perpetual licenses need to negotiate with Sitecore to add this capability to their license. XM Cloud is where Sitecore is innovating.

Licensing 52

Licensing Licensing Packaging Marketing 52

Drug Discovery World

AUGUST 5, 2022

Ian Hollingsworth, Associate Director of product development at Boyds, the global drug development consultancy, explains the benefits to the drug development lifecycle of building strong partnerships with external consultants, and when and how to get the best from them. Why sponsors use external consultants.

Drug Development 130

Drug Development Drugs Pharma Companies International 130

Molecule Blog

JANUARY 9, 2023

IP-NFTs upgrade our legacy intellectual system by unifying IP (patents, legal), underlying data (through decentralized storage and access control), and economics (royalties, license fees, sales) into one programmable, transactable, digital unit. ‍ How will IP-NFTs enable drug development in the future?

Research 52

Research Licensing Licensing Science 52

Drug Discovery World

JANUARY 2, 2024

The third is the market.” Elaborating, Dr Bekheet notes that the quality of the team came up across various talks throughout the Innovation Summit, and stipulates that what really matters is identifying where the team’s strength lies, where the skill set is, whether there are gaps within the team, and trying to build a cohesive team.

Research 147

Research Vaccine Science Trials 147

FDA Law Blog: Biosimilars

MARCH 13, 2024

After all, it never invested the time and resources necessary to obtain approval for commercial marketing or use. the marketing applicant before the Food and Drug Administration to support the application for patent term extension of U.S. That was the case in the PTO’s April 3, 1995 decision denying a PTE as to U.S. Lehman , No.

FDA 59

FDA FDA Approval Marketing Production 59

The Pharma Data

NOVEMBER 8, 2020

The Series B financing will be mainly used to conduct global clinical trials, research and development, and product in-licensing activities. Inmagene is a leading drug development company focused on immunology-related therapeutic areas. To date, Inmagene has raised over $40 million financing.

Clinical Trials 40

Clinical Trials Licensing Licensing Trials 40

Drug Target Review

NOVEMBER 22, 2023

Whilst TGF-β is an attractive target for cancer therapy because of its critical role in promoting tumor aggressiveness, immune escape and resistance to therapy, activation of alternative resistance pathways has hindered drug development attempts in the past. Pancreatic cancer is a very difficult cancer to treat.

Licensing 52

Licensing Licensing Small Molecule Therapies 52

Perficient: Drug Development

FEBRUARY 14, 2024

But there’s one more type of training your healthcare content strategists and marketers need that you’re (probably) not doing: healthcare writing training. The skills that often are part of successful digital marketing in other areas of commerce don’t always translate exactly to healthcare marketing. And it’s not you.

Engineering 52

Engineering International Marketing Compliance 52

Drug Discovery World

JANUARY 31, 2023

Teams must plan for post-approval activities while managing spend—and waiting nervously for regulatory approvals like their Prescription Drug User Fee Act (PDUFA) date to arrive. Mature organisations must race to deliver key new patient therapeutics while meeting market revenue expectations.

Production 246

Production Engineering Pharmaceutical Companies Clinical Trials 246

Molecule Blog

AUGUST 19, 2021

In drug development however, when a therapeutic is discovered, or research becomes more akin to product development, the source of funding must change. This is the point where no-strings-attached funding fails to link up with profit-motivated funding to turn a recent discovery into a product on the market.

Research 52

Research Licensing Licensing Drug Development 52

Perficient: Drug Development

NOVEMBER 10, 2023

Depending on the size of the team and anticipated activity within a program, additional RDEs can also be provisioned, however, this may come at an additional licensing cost from Adobe. Creating an Rapid Development Environment The RDE can be provisioned with a Program via Cloud Manager in AEM as a Cloud Service.

Packaging 105

Packaging Licensing Licensing International 105

LifeSciVC

JULY 17, 2024

By Mike Cloonan, Chief Executive Officer of Sionna Therapeutics, as part of the From The Trenches feature of LifeSciVC The drug development process in rare diseases is rife with challenges especially when companies target significant differentiation or first-in-class targets.

Clinical Research 45

Clinical Research Disease Research Clinical Trials 45

Crown Bioscience

MAY 4, 2021

Among the 180+ cancer drugs approved by the FDA since 1995, only 14 have been approved for pediatric use, with another 26 used off-label (i.e. used in a way that is not described in the license), and only three drugs have been approved exclusively for use in children.

Research 52

Research Pharmaceutical Companies Licensing Licensing 52

The Pharma Data

AUGUST 21, 2020

Eli Lilly, on the heels of detailing a clinical win in China for PD-1 inhibitor Tyvyt, has decided to take a bigger stake in the drug developed by partner Innovent Biologics in an expanded deal that could vault it into the lucrative—yet ultra-competitive—U.S. lung cancer market. market, with Merck & Co.’s

Licensing 52

Licensing Licensing FDA Marketing 52

Perficient: Drug Development

OCTOBER 27, 2023

Spartacus is an open-source JavaScript framework developed by SAP for building modern, responsive, and feature-rich e-commerce storefronts. The Composable Storefront emerged as an ideal solution for expedited market entry. This solution reduces time to market for SAP Commerce new implementations, upgrades, and migrations.

Compliance 105

Compliance Licensing Licensing Marketing 105

Perficient: Drug Development

JUNE 7, 2023

Magento offers powerful marketing, search engine optimization, and Catalog management tools. Magento is a largely customizable E-Commerce platform available under both open-source and marketable licenses. Salesforce is a popular CRM tool for support, deals, and marketing brigades worldwide. I hope it’s useful.

Licensing 52

Licensing Licensing Engineering Marketing 52